NQVAX vs. FALIX

Last updated Jun 4, 2026

NQVAX (Nuveen Multi-Cap Value Fund Class A) and FALIX (Fidelity Advisor Large Cap Fund Class I) are both Large Cap Value Equities funds. Over the past 10 years, NQVAX returned 12.66%/yr vs 14.12%/yr for FALIX. Their correlation of 0.91 suggests significant overlap in exposure. NQVAX charges 1.15%/yr vs 0.54%/yr for FALIX.

Performance

NQVAX vs. FALIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nuveen Multi-Cap Value Fund Class A (NQVAX) and Fidelity Advisor Large Cap Fund Class I (FALIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

Over the past 10 years, NQVAX has underperformed FALIX with an annualized return of 12.66%, while FALIX has yielded a comparatively higher 14.12% annualized return.

NQVAX

• 1D: 0.44%
• 1M: 1.61%
• YTD: 13.25%
• 6M: 14.26%
• 1Y: 31.93%
• 3Y*: 19.97%
• 5Y*: 12.57%
• 10Y*: 12.66%

FALIX

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 12.07%
• 3Y*: 19.09%
• 5Y*: 12.39%
• 10Y*: 14.12%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NQVAX vs. FALIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NQVAX Nuveen Multi-Cap Value Fund Class A	13.25%	17.62%	18.95%	15.65%	-1.27%	28.22%	-0.51%	29.99%	-14.58%	18.37%
FALIX Fidelity Advisor Large Cap Fund Class I	0.00%	19.65%	26.36%	23.49%	-7.91%	25.81%	8.85%	31.71%	-8.42%	16.93%

Correlation

The correlation between NQVAX and FALIX is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.44
Correlation (3Y) Calculated over the trailing 3-year period	0.72
Correlation (5Y) Calculated over the trailing 5-year period	0.84
Correlation (10Y) Calculated over the trailing 10-year period	0.89
Correlation (All Time) Calculated using the full available price history since Dec 9, 2002	0.91

Over the past year, the correlation between NQVAX and FALIX has dropped to 0.44 - well below their long-term average of 0.91, suggesting their price drivers have been diverging.

Return for Risk

NQVAX vs. FALIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NQVAX

NQVAX Risk / Return Rank: 78
NQVAX Sharpe Ratio Rank: 77
NQVAX Sortino Ratio Rank: 72
NQVAX Omega Ratio Rank: 64
NQVAX Calmar Ratio Rank: 89
NQVAX Martin Ratio Rank: 88

FALIX

FALIX Risk / Return Rank: 45
FALIX Sharpe Ratio Rank: 38
FALIX Sortino Ratio Rank: 37
FALIX Omega Ratio Rank: 74
FALIX Calmar Ratio Rank: 57
FALIX Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NQVAX vs. FALIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nuveen Multi-Cap Value Fund Class A (NQVAX) and Fidelity Advisor Large Cap Fund Class I (FALIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NQVAX	FALIX	Difference
Sharpe ratio: Return per unit of total volatility	2.55	1.81	+0.74
Sortino ratio: Return per unit of downside risk	3.54	2.54	+1.00
Omega ratio: Gain probability vs. loss probability	1.45	1.49	-0.04
Calmar ratio: Return relative to maximum drawdown	4.48	2.89	+1.59
Martin ratio: Return relative to average drawdown	17.15	4.92	+12.23
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NQVAX vs. FALIX - Sharpe Ratio Comparison

The current NQVAX Sharpe Ratio is 2.55, which is higher than the FALIX Sharpe Ratio of 1.81. The chart below compares the historical Sharpe Ratios of NQVAX and FALIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NQVAX	FALIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.55	1.81	+0.74
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.78	0.78	0.00
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.67	0.77	-0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.45	0.48	-0.02

Drawdowns

NQVAX vs. FALIX - Drawdown Comparison

The maximum NQVAX drawdown since its inception was -67.90%, which is greater than FALIX's maximum drawdown of -62.37%. Use the drawdown chart below to compare losses from any high point for NQVAX and FALIX.

Drawdown Indicators

	NQVAX	FALIX	Difference
Max Drawdown Largest peak-to-trough decline	-67.90%	-62.37%	-5.53%
Max Drawdown (1Y) Largest decline over 1 year	-7.41%	-5.03%	-2.38%
Max Drawdown (3Y) Largest decline over 3 years	-18.01%	-18.89%	+0.88%
Max Drawdown (5Y) Largest decline over 5 years	-18.01%	-21.48%	+3.47%
Max Drawdown (10Y) Largest decline over 10 years	-42.29%	-37.51%	-4.78%
Current Drawdown Current decline from peak	-1.22%	-4.17%	+2.95%
Average Drawdown Average peak-to-trough decline	-11.81%	-13.28%	+1.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.93%	2.78%	-0.85%

Volatility

NQVAX vs. FALIX - Volatility Comparison

Nuveen Multi-Cap Value Fund Class A (NQVAX) has a higher volatility of 4.36% compared to Fidelity Advisor Large Cap Fund Class I (FALIX) at 0.00%. This indicates that NQVAX's price experiences larger fluctuations and is considered to be riskier than FALIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NQVAX	FALIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.36%	0.00%	+4.36%
Volatility (6M) Calculated over the trailing 6-month period	9.85%	4.20%	+5.65%
Volatility (1Y) Calculated over the trailing 1-year period	13.00%	8.06%	+4.94%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.25%	16.44%	-0.19%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.11%	18.58%	+0.53%

NQVAX vs. FALIX - Expense Ratio Comparison

NQVAX has a 1.15% expense ratio, which is higher than FALIX's 0.54% expense ratio.

Dividends

NQVAX vs. FALIX - Dividend Comparison

NQVAX's dividend yield for the trailing twelve months is around 1.46%, less than FALIX's 5.86% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FALIX Fidelity Advisor Large Cap Fund Class I	5.86%	5.86%	6.10%	3.43%	2.28%	6.51%	5.39%	8.35%	16.78%	6.13%	2.25%	3.16%
NQVAX Nuveen Multi-Cap Value Fund Class A	1.46%	1.66%	1.62%	1.06%	1.17%	1.23%	3.17%	1.10%	0.00%	1.76%	0.79%	0.78%

Frequently Asked Questions

Can I hold both NQVAX and FALIX in my portfolio?

NQVAX and FALIX have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NQVAX or FALIX?

NQVAX has higher volatility (4.36%) compared to FALIX (0.00%). In terms of maximum drawdown, NQVAX dropped -67.90% vs FALIX's -62.37%.

Which has better risk-adjusted returns?

NQVAX currently has the higher Sharpe Ratio (2.55 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.